Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients

ASAIO Journal

Volumn 53, Issue 3, 2007, Pages 324-328

  Sakamoto, Yuichiro ^a   Mashiko, Kunihiro ^a   Matsumoto, Hisashi ^a   Hara, Yoshiaki ^a   Kutsukata, Noriyoshi ^a   Yamamoto, Yasuhiro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; BLOOD; BLOOD PRESSURE; PATIENT TREATMENT; PROTEINS;

CIRCULATION DYNAMICS; DIRECT HEMOPERFUSION (DHP); PLASMINOGEN ACTIVATORS; SERUM ENDOTOXIN LEVELS;

FIBERS;

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR; POLYMYXIN B;

ADULT; AGED; ARTICLE; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; FEMALE; HEMOPERFUSION; HUMAN; MALE; MORTALITY; OXYGEN TENSION; PROTEIN ANALYSIS; SEPTIC SHOCK; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BLOOD PRESSURE; ENDOTOXINS; FEMALE; HEMOPERFUSION; HMGB1 PROTEIN; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMYXIN B; PROTEIN C; SHOCK, SEPTIC;

EID: 34248999063     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e3180340301     Document Type: Article

References (29)

1. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure for the use of innovative therapies in sepsis. Chest 101: 1644-1655, 1992.
2. Angus D, Wax RS: Epidemiology of sepsis: an update. Crit Care Med 7: 109-116, 2001.
3. Sato T, Shoji H, Koga N: Endotoxin adsorption by polymyxin B immobilized fiber column in patients with systemic inflammatory response syndrome: the Japan experience. Ther Apher Dial 7: 252-258, 2003.
4. Tani T, Hanasawa K, Kodama M, et al: Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 in septic patients. World J Surg 25: 660-668, 2001.
5. Hussein MH, Kato T, Sugiura T, et al: Effect of hemoperfusion using polymyxin b-immobilized fiber on IL-6, HMGB-1, and IFN gamma in a neonatal sepsis model. Pedi Res 58: 309-314, 2005.
6. Wang H, Bloom O, Zhang M, et al: HMGB-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251, 1999.
7. Goodwin GH, Sanders C, Johns EW: A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem 38: 14-19, 1973.
8. Yang H, Wang H, Czura CJ, Tracey KJ: The cytokine activity of HMGB1. J Leukocyte Biol 8: 1-8, 2005.
9. Sakamoto Y, Mashiko K, Matsumoto H, et al: Effect of direct hemoperfusion with a polymyxin B immobilized fiber column on high mobility group box-1 (HMGB-1) in severe septic shock: Report of a Case. ASAIO J 52: e37, 2006.
10. Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE: APACHE: Acute physiology and chronic health evaluation: a physiological based classification system. Crit Care Med 9: 571-579, 1981.
11. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Int Care Med 22: 707-710, 1996.
12. Ueno T, Sugino M, Nemoto H, et al: Effect over time of endotoxin adsorption therapy in sepsis. Ther Apher Dial 9: 128-136, 2005.
13. Shoji H: Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial 7: 108-114, 2003.
14. Nakamura T, Kawagoe Y, Ueda Y, Koide H: Polymyxin B-immobilized fiber hemoperfusion with low priming volume in an elderly septic shock patient with marked endotoxemia. ASAIO J 51: 482-484, 2005.
15. Nakamura T, Matsuda T, Suzuki Y, et al: Polymyxin B-immobilized fiber hemoperfusion in patients with sepsis. Dial Transplant 32: 602-607, 2003.
16. Nakamura T, Ebihara I, Shoji H, et al: Treatment with polymyxin B-immobilized fiber reduces platelet activation in septic shock patients: decrease in plasma levels of soluble P-selectin, platelet factor-4 and β-thromboglobulin. Inflamm Res 48: 171-175, 1999.
17. Anqstwunm MW, Gaertner R, Schopohl J: Outcome in elderly patients with severe infection is influenced by sex hormones but not gender. Crit Care Med 33: 2786-2793, 2005.
18. Wang H, Vishnubhakat JM, Bloom O, et al: Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 126: 389-392, 1999.
19. Ombrellino M, Wang H, Ajemian MS, et al: Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock. Lancet 354: 1446-1447, 1999.
20. Ueno H, Matsuda T, Hashimoto S, et al: Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 170: 1310-1316, 2004.
21. Kokkola R, Sundberg E, Ulfgren AK, et al: High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum 46: 2598-2603, 2002.
22. Andersson U, Wang H, Palmblad K, et al: High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192: 565-570, 2000.
23. Fiuza C, Bustin M, Talwar S, et al: Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101: 2652-2660, 2002.
24. Nakamura T, Ebihara I, Shimada N, Koide H: Changes in plasma erythropoietin and interleukin-6 concentrations in patients with septic shock after hemoperfusion with polymyxin B-immobilized fiber. Int Care Med 24: 1272-1276, 1998.
25. Vincent JL, Laterre PF, Cohen J, et al: A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 23: 400-405, 2005.
26. Fernandes CJ Jr, Akamine N, Knobel E: Cardiac troponin: a new serum marker of myocardial injury in sepsis. Int Care Med 25: 1165-1168, 1999.
27. Nakamura T, Ushiyama C, Shoji H, Koide H: Effect of hemoperfusion on serum cardiac troponin T concentrations using polymixin B-immobilized fibers in septic patients undergoing hemodialysis. ASAIO J 48: 41- 44, 2002.
28. Wang Y, Liu Y, Ito Y, et al: Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock. Anal Biochem 294: 73-82, 2001.
29. Hoshiai K, Hattan N, Fukuyama N, et al: Increased plasma tetrahydrobiopterin in septic shock is a possible therapeutic target. Pathophysiology 7: 275-281, 2001.